2012-21093. Advisory Commission on Childhood Vaccines, Notice of Meeting  

  • Start Preamble

    In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), notice is hereby given of the following meeting:

    Name: Advisory Commission on Childhood Vaccines (ACCV).

    Date and Time: September 06, 2012, 1:00 p.m. to 5:15 p.m. EDT.

    Place: Parklawn Building (and via audio conference call), Conference Room 10-65, 5600 Fishers Lane, Rockville, MD 20857.

    The ACCV will meet on Thursday, September 06 from 1:00 p.m. to 5:15 p.m. (EDT). The public can join the meeting via audio conference call by dialing 1-800-369-3104 on September 06, and providing the following information:

    Leader's Name: Dr. Geoffrey Evans

    Password: ACCV

    Agenda: The agenda items for the September meeting will include, but are not limited to: Updates from the Division of Vaccine Injury Compensation (DVIC), Department of Justice (DOJ), National Vaccine Program Office (NVPO), Immunization Safety Office (Centers for Disease Control and Prevention), National Institute of Allergy and Infectious Diseases (National Institutes of Health) and Center for Biologics Evaluation and Research (Food and Drug Administration). A draft agenda and additional meeting materials will be posted on the ACCV web site (http://www.hrsa.gov/​vaccinecompensation/​accv.htm) prior to the meeting. Agenda items are subject to change as priorities dictate.

    Public Comment: Persons interested in attending the meeting in person or providing an oral presentation should submit a written request, along with a copy of their presentation to: Annie Herzog, DVIC, Healthcare Systems Bureau (HSB), Health Resources and Services Administration (HRSA), Room 11C-26, 5600 Fishers Lane, Rockville, Maryland 20857 or email: aherzog@hrsa.gov. Requests should contain the name, address, telephone number, email address, and any business or professional affiliation of the person desiring to make an oral presentation. Groups having similar interests are requested to combine their comments and present them through a single representative. The allocation of time may be adjusted to accommodate the level of expressed interest. DVIC will notify each presenter by email, mail, or telephone of their assigned presentation time. Persons who do not file an advance request for a presentation, but desire to make an oral statement, may announce it at the time of the public comment period. Public participation and ability to comment will be limited to space and time as available.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Anyone requiring information regarding the ACCV should contact Annie Herzog, DVIC, HSB, HRSA, Room 11C-26, 5600 Fishers Lane, Rockville, MD 20857; telephone (301) 443-6593, or email: aherzog@hrsa.gov.

    Start Signature

    Dated: August 22, 2012.

    Bahar Niakan,

    Director, Division of Policy and Information Coordination.

    End Signature End Further Info End Preamble

    [FR Doc. 2012-21093 Filed 8-27-12; 8:45 am]

    BILLING CODE 4165-15-P

Document Information

Published:
08/28/2012
Department:
Health Resources and Services Administration
Entry Type:
Notice
Document Number:
2012-21093
Pages:
52041-52041 (1 pages)
PDF File:
2012-21093.pdf